Cargando…
Treatment of Minimal Residual Disease in Breast Cancer: A Longitudinal Case Study
The presence of micrometastatic disease will ultimately determine the breast cancer-specific mortality of patients treated according to current guidelines. Minimal residual disease (i.e., occult tumor, not detected by conventional tests) may exist in two forms: a dormant form of only micrometastasis...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779321/ https://www.ncbi.nlm.nih.gov/pubmed/29383298 http://dx.doi.org/10.7759/cureus.1521 |